These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22180471)

  • 21. Beyond scoring: a modern interpretation of disease progression in chronic liver disease.
    Rosselli M; MacNaughtan J; Jalan R; Pinzani M
    Gut; 2013 Sep; 62(9):1234-41. PubMed ID: 23645629
    [No Abstract]   [Full Text] [Related]  

  • 22. [Liver resection after downstaging with systemic chemotherapy in a case of a multicentric hepatocellular carcinoma with virus B cirrhosis].
    Ionescu M; Dumitraşcu T; Stroescu C
    Chirurgia (Bucur); 2007; 102(3):337-43. PubMed ID: 17687865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of liver diseases in Korea: liver cirrhosis.
    Jang JW
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S40-9. PubMed ID: 20037279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum NT-proCNP concentrations are elevated in patients with chronic liver diseases and associated with complications and unfavorable prognosis of cirrhosis.
    Koch A; Zimmermann HW; Baeck C; Schneider C; Yagmur E; Trautwein C; Tacke F
    Clin Biochem; 2012 Apr; 45(6):429-35. PubMed ID: 22285383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognosis of liver cirrhosis: results of a 14-year-long clinical follow-up study].
    Marosi L; Ferenci P; Dragosics B; Kiss F; Pollak C; Minar E
    Schweiz Med Wochenschr; 1983 Oct; 113(43):1586-92. PubMed ID: 6316488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The natural history of non-alcoholic fatty liver disease.
    Caldwell S; Argo C
    Dig Dis; 2010; 28(1):162-8. PubMed ID: 20460906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long course and prognostic factors of virus-induced cirrhosis of the liver.
    Gentilini P; Laffi G; La Villa G; Romanelli RG; Buzzelli G; Casini-Raggi V; Melani L; Mazzanti R; Riccardi D; Pinzani M; Zignego AL
    Am J Gastroenterol; 1997 Jan; 92(1):66-72. PubMed ID: 8995940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long-term pathological evolution of chronic hepatitis C.
    Yano M; Kumada H; Kage M; Ikeda K; Shimamatsu K; Inoue O; Hashimoto E; Lefkowitch JH; Ludwig J; Okuda K
    Hepatology; 1996 Jun; 23(6):1334-40. PubMed ID: 8675148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis in chronic liver disease and its complications.
    Coulon S; Heindryckx F; Geerts A; Van Steenkiste C; Colle I; Van Vlierberghe H
    Liver Int; 2011 Feb; 31(2):146-62. PubMed ID: 21073649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term prognosis of chronic B and C viral hepatitis].
    Ohlen J; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.
    Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S
    Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
    Cucchetti A; Ercolani G; Cescon M; Ravaioli M; Zanello M; Del Gaudio M; Lauro A; Vivarelli M; Grazi GL; Pinna AD
    J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral hepatitis and cirrhosis.
    Sherlock S
    Clin Gastroenterol; 1975 May; 4(2):281-95. PubMed ID: 165021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of portal hypertension in hepatic cirrhosis in relation to etiologic factors].
    Aiello A; Calapristi I; Freni MA; Fava A; Scarpignato EM; Spadaro A; Ferraú O
    Minerva Gastroenterol Dietol; 1993 Mar; 39(1):1-5. PubMed ID: 8357880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation.
    Heidelbaugh JJ; Bruderly M
    Am Fam Physician; 2006 Sep; 74(5):756-62. PubMed ID: 16970019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physiopathologic diagnosis of liver cirrhosis].
    Fujisawa K
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1598-604. PubMed ID: 1663535
    [No Abstract]   [Full Text] [Related]  

  • 40. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.
    Kim MY; Cho MY; Baik SK; Park HJ; Jeon HK; Im CK; Won CS; Kim JW; Kim HS; Kwon SO; Eom MS; Cha SH; Kim YJ; Chang SJ; Lee SS
    J Hepatol; 2011 Nov; 55(5):1004-9. PubMed ID: 21354227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.